Resultats de la cerca - Brain, Etienne
- Mostrar 1 - 20 resultats de 38
- Anar a la pàgina següent
-
1
-
2
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized study per Brain, Etienne G C, Rezai, Kevan, Lokiec, François, Gutierrez, Maya, Urien, Saïk
Publicat 2008Text -
3
Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE) per Servagi-Vernat, Stéphanie, Créhange, Gilles, Bonnetain, Franck, Mertens, Cécile, Brain, Etienne, Bosset, Jean François
Publicat 2017Text -
4
-
5
Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International Survey per Frelaut, Maxime, De Glas, Nienke, Zapardiel, Ignacio, Kaidar-Person, Orit, Kfoury, Maria, You, Benoit, Banerjee, Susana, Brain, Etienne, Falandry, Claire, Rodrigues, Manuel
Publicat 2019Text -
6
Taking care of older patients with cancer in the context of COVID-19 pandemic per Mourey, Loïc, Falandry, Claire, de Decker, Laure, Boulahssass, Rabia, Carola, Elisabeth, Bengrine Lefevre, Leila, Cudennec, Tristan, Brain, Etienne, Paillaud, Eléna, Soubeyran, Pierre
Publicat 2020Text -
7
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity per Brignone, Chrystelle, Gutierrez, Maya, Mefti, Fawzia, Brain, Etienne, Jarcau, Rosana, Cvitkovic, Frédérique, Bousetta, Nabil, Medioni, Jacques, Gligorov, Joseph, Grygar, Caroline, Marcu, Manon, Triebel, Frédéric
Publicat 2010Text -
8
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study per Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves
Publicat 2012Text -
9
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival per Rochefort, Pauline, Chabaud, Sylvie, Pierga, Jean-Yves, Tredan, Olivier, Brain, Etienne, Bidard, François-Clément, Schiffler, Camille, Polena, Helena, Khalil-Mgharbel, Abir, Vilgrain, Isabelle, Bachelot, Thomas
Publicat 2017Text -
10
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2... per Wildiers, Hans, Meyskens, Thomas, Marréaud, Sandrine, Lago, Lissandra Dal, Vuylsteke, Peter, Curigliano, Giuseppe, Waters, Simon, Brouwers, Barbara, Meulemans, Bart, Sousa, Berta, Poncet, Coralie, Brain, Etienne
Publicat 2022Text -
11
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer per Janni, Wolfgang, Sarosiek, Tomasz, Karaszewska, Boguslawa, Pikiel, Joanna, Staroslawska, Elzbieta, Potemski, Piotr, Salat, Christoph, Brain, Etienne, Caglevic, Christian, Briggs, Kathryn, DeSilvio, Michelle, Marini, Luca, Papadimitriou, Christos
Publicat 2014Text -
12
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated... per Sabatier, Renaud, Diéras, Véronique, Pivot, Xavier, Brain, Etienne, Roché, Henri, Extra, Jean-Marc, Monneur, Audrey, Provansal, Magali, Tarpin, Carole, Bertucci, François, Viens, Patrice, Zemmour, Christophe, Gonçalves, Anthony
Publicat 2018Text -
13
Perspectives on cancer care in older patients in France per Hauchecorne, Mathilde, Pierro, Monica, Brain, Etienne, Bringuier, Michael, Soubeyran, Pierre, Chakiba, Camille, Mathoulin-Pelissier, Simone, Paillaud, Elena, Geiss, Romain, Besse, Benjamin, Mourey, Loïc, Vincent, Hélène, Baldini, Capucine
Publicat 2020Text -
14
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial per Cabel, Luc, Berger, Frédérique, Cottu, Paul, Loirat, Delphine, Rampanou, Aurore, Brain, Etienne, Cyrille, Stacy, Bourgeois, Hugues, Kiavue, Nicolas, Deluche, Elise, Ladoire, Sylvain, Campone, Mario, Pierga, Jean-Yves, Bidard, Francois-Clement
Publicat 2021Text -
15
Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy per Cabel, Luc, Rosenblum, Dan, Lerebours, Florence, Brain, Etienne, Loirat, Delphine, Bergqvist, Mattias, Cottu, Paul, Donnadieu, Anne, Bethune, Anne, Kiavue, Nicolas, Rodrigues, Manuel, Pierga, Jean-Yves, Tanguy, Marie-Laure, Bidard, François-Clément
Publicat 2020Text -
16
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial per Hamy, Anne-Sophie, Tury, Sandrine, Wang, Xiaofei, Gao, Junheng, Pierga, Jean-Yves, Giacchetti, Sylvie, Brain, Etienne, Pistilli, Barbara, Marty, Michel, Espié, Marc, Benchimol, Gabriel, Laas, Enora, Laé, Marick, Asselain, Bernard, Aouchiche, Brice, Edelman, Martin, Reyal, Fabien
Publicat 2019Text -
17
Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial per López-Miranda, Elena, Pérez-García, José Manuel, Di Cosimo, Serena, Brain, Etienne, Ravnik, Maja, Escrivá-de-Romaní, Santiago, Vidal, Maria, Gligorov, Joseph, Borštnar, Simona, Calabuig, Laura, Sampayo-Cordero, Miguel, Malfettone, Andrea, Llombart-Cussac, Antonio, Suter, Thomas M., Cortés, Javier
Publicat 2020Text -
18
International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer per Wildiers, Hans, Heeren, Pieter, Puts, Martine, Topinkova, Eva, Janssen-Heijnen, Maryska L.G., Extermann, Martine, Falandry, Claire, Artz, Andrew, Brain, Etienne, Colloca, Giuseppe, Flamaing, Johan, Karnakis, Theodora, Kenis, Cindy, Audisio, Riccardo A., Mohile, Supriya, Repetto, Lazzaro, Van Leeuwen, Barbara, Milisen, Koen, Hurria, Arti
Publicat 2014Text -
19
Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial per Jacot, William, Cottu, Paul, Berger, Frederique, Dubot, Coraline, Venat-Bouvet, Laurence, Lortholary, Alain, Bourgeois, Hugues, Bollet, Marc, Servent, Veronique, Luporsi, Elisabeth, Espié, Marc, Guiu, Severine, D’Hondt, Veronique, Dieras, Veronique, Sablin, Marie-Paule, Brain, Etienne, Neffati, Souhir, Pierga, Jean-Yves, Bidard, Francois-Clement
Publicat 2019Text -
20
Phase III trial (EORTC 10994/BIG 1-00) assessing the value of p53 using a functional assay to predict sensitivity to a taxane versus non taxane primary chemotherapy in breast cance... per Bonnefoi, Hervé, Piccart, Martine, Bogaerts, Jan, Mauriac, Louis, Fumoleau, Pierre, Brain, Etienne, Petit, Thierry, Rouanet, Philippe, Jassem, Jacek, Blot, Emmanuel, Zaman, Khalil, Cufer, Tanja, Lortholary, Alain, Lidbrink, Elisabet, André, Sylvie, Litière, Saskia, Lago, Lissandra Dal, Becette, Véronique, Cameron, David A., Bergh, Jonas, Iggo, Richard
Publicat 2011Text